ASRS 2020: Endolaserless Vitrectomy With Aflibercept Monotherapy Leads to Significant Visual Gains in PDR-Related Vitreous Hemorrhage
Persistent, frequent postoperative anti-VEGF therapy is needed to optimize outcomes and reduce complications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.